United States Lancets Market Report 2017

December 2017 | 108 pages | ID: U720CB59AE3EN
QYResearch

Abstracts

In this report, the United States Lancets market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Lancets in these regions, from 2012 to 2022 (forecast).

United States Lancets market competition by top manufacturers/players, with Lancets sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• Lifescan
• BD
• Bayer
• Abbott
• B. Braun
• ARKRAY
• Terumo
• I-SENS
• Nipro
• Omron
• Infopia
• AgaMatrix
• Smiths Medical
• Sarstedt
• SANNUO
• Yicheng
• Yuwell
• Greiner Bio One

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Safety Lancets
• Homecare Lancets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Lancets for each application, including

• Cholesterol Tests
• Glucose Tests
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Lancets Market Report 2017

1 LANCETS OVERVIEW

1.1 Product Overview and Scope of Lancets
1.2 Classification of Lancets by Product Category
  1.2.1 United States Lancets Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lancets Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Safety Lancets
  1.2.4 Homecare Lancets
1.3 United States Lancets Market by Application/End Users
  1.3.1 United States Lancets Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cholesterol Tests
  1.3.3 Glucose Tests
  1.3.4 Others
1.4 United States Lancets Market by Region
  1.4.1 United States Lancets Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lancets Status and Prospect (2012-2022)
  1.4.3 Southwest Lancets Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lancets Status and Prospect (2012-2022)
  1.4.5 New England Lancets Status and Prospect (2012-2022)
  1.4.6 The South Lancets Status and Prospect (2012-2022)
  1.4.7 The Midwest Lancets Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lancets (2012-2022)
  1.5.1 United States Lancets Sales and Growth Rate (2012-2022)
  1.5.2 United States Lancets Revenue and Growth Rate (2012-2022)

2 UNITED STATES LANCETS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lancets Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lancets Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lancets Average Price by Players/Suppliers (2012-2017)
2.4 United States Lancets Market Competitive Situation and Trends
  2.4.1 United States Lancets Market Concentration Rate
  2.4.2 United States Lancets Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lancets Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LANCETS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lancets Sales and Market Share by Region (2012-2017)
3.2 United States Lancets Revenue and Market Share by Region (2012-2017)
3.3 United States Lancets Price by Region (2012-2017)

4 UNITED STATES LANCETS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lancets Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lancets Revenue and Market Share by Type (2012-2017)
4.3 United States Lancets Price by Type (2012-2017)
4.4 United States Lancets Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LANCETS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lancets Sales and Market Share by Application (2012-2017)
5.2 United States Lancets Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LANCETS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lancets Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Lifescan
  6.2.2 Lancets Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 BD
  6.3.2 Lancets Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.2 Lancets Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott
  6.5.2 Lancets Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 B. Braun
  6.6.2 Lancets Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 ARKRAY
  6.7.2 Lancets Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Terumo
  6.8.2 Lancets Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 I-SENS
  6.9.2 Lancets Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Nipro
  6.10.2 Lancets Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Omron
6.12 Infopia
6.13 AgaMatrix
6.14 Smiths Medical
6.15 Sarstedt
6.16 SANNUO
6.17 Yicheng
6.18 Yuwell
6.19 Greiner Bio One

7 LANCETS MANUFACTURING COST ANALYSIS

7.1 Lancets Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lancets

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lancets Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lancets Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LANCETS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lancets Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lancets Sales Volume Forecast by Type (2017-2022)
11.3 United States Lancets Sales Volume Forecast by Application (2017-2022)
11.4 United States Lancets Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lancets
Figure United States Lancets Market Size (K Units) by Type (2012-2022)
Figure United States Lancets Sales Volume Market Share by Type (Product Category) in 2016
Figure Safety Lancets Product Picture
Figure Homecare Lancets Product Picture
Figure United States Lancets Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Lancets by Application in 2016
Figure Cholesterol Tests Examples
Table Key Downstream Customer in Cholesterol Tests
Figure Glucose Tests Examples
Table Key Downstream Customer in Glucose Tests
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Lancets Market Size (Million USD) by Region (2012-2022)
Figure The West Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lancets Sales (K Units) and Growth Rate (2012-2022)
Figure United States Lancets Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lancets Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Lancets Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Lancets Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lancets Sales Share by Players/Suppliers
Figure 2017 United States Lancets Sales Share by Players/Suppliers
Figure United States Lancets Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lancets Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lancets Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lancets Revenue Share by Players/Suppliers
Figure 2017 United States Lancets Revenue Share by Players/Suppliers
Table United States Market Lancets Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Lancets Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Lancets Market Share of Top 3 Players/Suppliers
Figure United States Lancets Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lancets Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lancets Product Category
Table United States Lancets Sales (K Units) by Region (2012-2017)
Table United States Lancets Sales Share by Region (2012-2017)
Figure United States Lancets Sales Share by Region (2012-2017)
Figure United States Lancets Sales Market Share by Region in 2016
Table United States Lancets Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lancets Revenue Share by Region (2012-2017)
Figure United States Lancets Revenue Market Share by Region (2012-2017)
Figure United States Lancets Revenue Market Share by Region in 2016
Table United States Lancets Price (USD/Unit) by Region (2012-2017)
Table United States Lancets Sales (K Units) by Type (2012-2017)
Table United States Lancets Sales Share by Type (2012-2017)
Figure United States Lancets Sales Share by Type (2012-2017)
Figure United States Lancets Sales Market Share by Type in 2016
Table United States Lancets Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lancets Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lancets by Type (2012-2017)
Figure Revenue Market Share of Lancets by Type in 2016
Table United States Lancets Price (USD/Unit) by Types (2012-2017)
Figure United States Lancets Sales Growth Rate by Type (2012-2017)
Table United States Lancets Sales (K Units) by Application (2012-2017)
Table United States Lancets Sales Market Share by Application (2012-2017)
Figure United States Lancets Sales Market Share by Application (2012-2017)
Figure United States Lancets Sales Market Share by Application in 2016
Table United States Lancets Sales Growth Rate by Application (2012-2017)
Figure United States Lancets Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Lancets Sales Growth Rate (2012-2017)
Figure Roche Lancets Sales Market Share in United States (2012-2017)
Figure Roche Lancets Revenue Market Share in United States (2012-2017)
Table Lifescan Basic Information List
Table Lifescan Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lifescan Lancets Sales Growth Rate (2012-2017)
Figure Lifescan Lancets Sales Market Share in United States (2012-2017)
Figure Lifescan Lancets Revenue Market Share in United States (2012-2017)
Table BD Basic Information List
Table BD Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Lancets Sales Growth Rate (2012-2017)
Figure BD Lancets Sales Market Share in United States (2012-2017)
Figure BD Lancets Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Lancets Sales Growth Rate (2012-2017)
Figure Bayer Lancets Sales Market Share in United States (2012-2017)
Figure Bayer Lancets Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Lancets Sales Growth Rate (2012-2017)
Figure Abbott Lancets Sales Market Share in United States (2012-2017)
Figure Abbott Lancets Revenue Market Share in United States (2012-2017)
Table B. Braun Basic Information List
Table B. Braun Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B. Braun Lancets Sales Growth Rate (2012-2017)
Figure B. Braun Lancets Sales Market Share in United States (2012-2017)
Figure B. Braun Lancets Revenue Market Share in United States (2012-2017)
Table ARKRAY Basic Information List
Table ARKRAY Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ARKRAY Lancets Sales Growth Rate (2012-2017)
Figure ARKRAY Lancets Sales Market Share in United States (2012-2017)
Figure ARKRAY Lancets Revenue Market Share in United States (2012-2017)
Table Terumo Basic Information List
Table Terumo Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Terumo Lancets Sales Growth Rate (2012-2017)
Figure Terumo Lancets Sales Market Share in United States (2012-2017)
Figure Terumo Lancets Revenue Market Share in United States (2012-2017)
Table I-SENS Basic Information List
Table I-SENS Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure I-SENS Lancets Sales Growth Rate (2012-2017)
Figure I-SENS Lancets Sales Market Share in United States (2012-2017)
Figure I-SENS Lancets Revenue Market Share in United States (2012-2017)
Table Nipro Basic Information List
Table Nipro Lancets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nipro Lancets Sales Growth Rate (2012-2017)
Figure Nipro Lancets Sales Market Share in United States (2012-2017)
Figure Nipro Lancets Revenue Market Share in United States (2012-2017)
Table Omron Basic Information List
Table Infopia Basic Information List
Table AgaMatrix Basic Information List
Table Smiths Medical Basic Information List
Table Sarstedt Basic Information List
Table SANNUO Basic Information List
Table Yicheng Basic Information List
Table Yuwell Basic Information List
Table Greiner Bio One Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lancets
Figure Manufacturing Process Analysis of Lancets
Figure Lancets Industrial Chain Analysis
Table Raw Materials Sources of Lancets Major Players/Suppliers in 2016
Table Major Buyers of Lancets
Table Distributors/Traders List
Figure United States Lancets Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Lancets Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lancets Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Lancets Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lancets Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lancets Sales Volume (K Units) Forecast by Type in 2022
Table United States Lancets Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lancets Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lancets Sales Volume (K Units) Forecast by Application in 2022
Table United States Lancets Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Lancets Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lancets Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lancets Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources